Ew.Ps

EW.PS maintains a capital structure characterized by significant leverage relative to its equity base, with total liabilities of PHP 495.6 billion against total equity of PHP 81.5 billion. The debt-to-equity ratio stands at 0.44, supported by long-term debt of PHP 36.1 billion. Liquidity is assessed as medium risk, with a key flag noting that net cash is negative after subtracting total debt. The company generates robust operating cash flow of PHP 8.6 billion and free cash flow of PHP 8.4 billion, which helps service its obligations despite the negative net cash position.

Profitability metrics indicate efficient capital utilization relative to book value, with a return on equity (ROE) of 9.5% and a return on assets (ROA) of 1.34%. The company trades at a compressed valuation multiple, with a price-to-earnings (P/E) ratio of 3.43 and a price-to-book (P/B) ratio of 0.33, suggesting the market prices the equity at a significant discount to its accounting value. Net income of PHP 9.2 billion on revenue of PHP 40.6 billion reflects a healthy net margin, supported by strong cash conversion from operations.

Revenue concentration and segment details are not explicitly broken down in the available data, but the company operates within the Medical Devices activity space. The geographic exposure is anchored by a headquarters in the United States of America, though specific regional revenue splits are not disclosed in the current snapshot. The company employs 16,000 people, indicating a substantial operational footprint consistent with a mid-to-large cap healthcare supplier.

Growth trajectory analysis is limited by the absence of historical period data in the input; however, the current revenue base of PHP 40.6 billion provides a scale reference for future expansion. The company’s ability to maintain free cash flow of PHP 8.4 billion suggests operational stability, which is a prerequisite for sustainable growth in the medical equipment sector. Without multi-year trend data, the direction of revenue growth remains unquantified in this assessment.

Risk factors include medium liquidity risk and low dilution risk, with the primary concern being the negative net cash position after debt subtraction. The company has a total share float of 573.6 million shares and 6,691 common-share holders, indicating a dispersed ownership structure that may limit immediate dilution pressure from insider sales. The low dilution risk assessment suggests that current capital structure needs are being met without significant equity issuance.

Recent observations highlight an actual EPS of 4.10 PHP, which aligns with the reported net income and share count. The company maintains strong governance and social ESG scores of 71 and 70 respectively, with low controversy scores of 14, suggesting stable stakeholder relations. The market capitalization is reported at USD 48.1 billion in IR references, which contrasts with the computed market cap of PHP 26.5 billion, indicating potential currency or data source discrepancies that require verification.

Revenue PHP 23.33B, +10,9% YoY; Net income +2,4% YoY.

• ▍Revenue PHP 23.33B, +10,9% YoY
• ▍Net income +2,4% YoY
• ▍Free cash flow −9,0% YoY
• ▍Net margin 19.8%

Revenue PHP 21.03B; Net margin 21.5%.

• ▍Revenue PHP 21.03B
• ▍Net margin 21.5%